Table 1:
Participant characteristics at baseline. Factors included in analyses are shown in bold.
| Total (n = 137) | Aβ42/Aβ40 − (n = 83) | Aβ42/Aβ40 +(n = 54)a | Testa | |
|---|---|---|---|---|
| Age, years | 73.80 ±4.76 | 72.84 ±4.51 | 75.28 ±4.79 | p < 0.01** |
| Sex, N = female, % | 62 (45.26) | 41 (49.40) | 21 (38.89) | p = 0.292 |
| Education, years | 16.50 ±2.27 | 16.25 ±2.27 | 16.87 ±2.25 | p = 0.120 |
| Raceb, N = White, % | 120 (87.59) | 69 (83.13) | 51 (94.44) | p = 0.064 |
| APOE ε4+ carrier, N, % | 47 (34.31) | 13 (15.66) | 34 (62.96) | p < 0.001*** |
| Biomarkers | ||||
| CSF: Aβ 42 /Aβ 40 | 0.074 ±0.023 | 0.091±0.008 | 0.048 ±0.010 | p < 0.001*** |
| CSF: t-Tau | 353.76 ±179.72 | 295.30 ±157.17 | 443.62 ±176.31 | p < 0.001*** |
| CSF: p-Tau | 46.91±22.82 | 36.28 ±14.80 | 63.25 ±23.42 | p < 0.001*** |
| MRI c : Hippocampal volume (normalized), cm 3 | 7.48 ±0.95 | 7.47 ±0.94 | 7.50 ±0.96 | p = 0.874 |
| Driving | ||||
| Trips with speeding, % | 9.02 ±9.29 | 9.18 ±8.69 | 8.80 ±10.21 | p = 0.821 |
| Trips with hard braking, % | 9.11 ±7.28 | 9.79 ±7.85 | 8.06 ±6.22 | p = 0.153 |
| Trips with hard acceleration, % | 4.11 ±6.67 | 4.03 ±6.82 | 4.24 ±6.49 | p = 0.863 |
| Trips with any adverse driving events, % | 18.53 ±12.76 | 19.16 ±12.43 | 17.57 ±13.31 | p = 0.485 |
| Trips, N | 2866.86 ±1615.77 | 3033.22 ±1656.63 | 2611.17 ±1530.75 | p = 0.130 |
| Cognitive assessment | ||||
| Free & Cued Serial Reminding Task, free recall score | 30.28 ±6.76 | 31.80 ±6.21 | 27.94 ±6.96 | p < 0.01** |
| Animal Fluency, total animals named | 21.09 ±4.86 | 21.34 ±4.97 | 20.72 ±4.71 | p = 0.466 |
| Trailmaking A, seconds to complete | 30.98 ±9.72 | 29.96 ±8.84 | 32.54 ±10.83 | p = 0.148 |
| Trailmaking B, seconds to complete | 75.93 ±29.18 | 75.80 ±30.11 | 76.15 ±27.96 | p = 0.944 |
| Composite score | −0.15 ±0.72 | −0.05 ±0.73 | −0.31 ±0.70 | p < 0.05* |
Means were compared using t-tests. Frequencies were compared using Fisher’s exact test.
The sample contains only Black and White races.
Data only available for 106 participants. Biomarker negative = 65 (61.32%), biomarker positive = 41 (38.68%).
APOE= Apolipoprotein E; CSF = Cerebrospinal fluid; MRI = Magnetic Resonance Imaging.
p<0.05;
p<0.01;
p<0.001